Found 85 clinical trials
C3421008 My type 2 diabetes. My life.
This study will assess tolerability, safety, and pharmacodynamics (PD) of twice daily (BID) administration of PF- 06882961 in adult participants with Type 2 Diabetes Mellitus (T2DM) who are treated with metformin and in non-diabetic adults with obesity
- 15 views
- 25 May, 2021
- 27 locations
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
Open-label, dose-confirmation and cohort expansion, multicentre, Phase Ib/II study to assess the anti-tumour activity and safety of MEN1611 in combination with cetuximab for the treatment of patients with PIK3CA mutated metastatic colorectal cancer.
- 2 views
- 27 Jan, 2021
- 39 locations
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
The main purpose of this open-label, dose-escalation, phase Ib study is to identify the appropriate dose of MEN1611 to be used in combination with Trastuzumab with/without Fulvestrant for the treatment of advanced or metastatic HER2-positive breast cancer
- 5 views
- 25 May, 2021
- 34 locations
Comparing the Stanford Letter Project Form to Traditional Advance Directives
Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.
- 0 views
- 24 Jan, 2021
- 1 location
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
with moderate to severe Glabellar Lines (GL) Step 2 (Phase II): does finding step in participants with moderate to severe GL Stage 2 (phase II) An evaluation of
- 0 views
- 28 Apr, 2021
- 1 location
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
The aim of this study is to identify new targets in cholesterol metabolism thanks to a genetically-based strategy.
- 0 views
- 24 Jan, 2021
- 1 location
The Swedish Essential Tremor (SWEET) Trial
To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.
- 7 views
- 23 Jan, 2021
- 7 locations
S1803 Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first
- 86 views
- 07 Mar, 2021
- 551 locations
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
for weekly echoes. Although mothers with low titer anti-Ro will not be continued in Step 2 and therefore not followed by FHRM, birth ECGs will be collected to confirm that low titer antibodies do not
- 42 views
- 26 Jan, 2021
- 32 locations
An Effectiveness-Implementation Trial of SPIRIT in ESRD
called "Sharing Patient's Illness Representation to Increase Trust" (SPIRIT). SPIRIT is a 6-step, 2-session, face-to-face intervention to promote cognitive and emotional preparation for end-of-life
- 74 views
- 19 Feb, 2021
- 40 locations